News
2d
Zacks Small Cap Research on MSNAEMD: Progressing & Expanding Clinical & Pre-Clinical Activities in Cost Efficient MannerAEMD READ THE FULL AEMD RESEARCH REPORT Assessing if the Hemopurifier in conjunction with standard of care treatment can increase the population that can benefit from combined treatment Aethlon ...
Natural products industry companies share overviews on the latest science on their dietary supplement branded ingredients and ...
I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced publication of the ...
4d
TipRanks on MSNCassava Sciences presents poster at TSC 2025 on SimufilamCassava Sciences (SAVA) announced that the Company presented a poster at the TSC International Research Conference held June 26-28, 2025 in ...
On April 26, 2025, Dr. Sarah Ronis, a Clinical & Translational Science (CTS) Research Program awardee and recent Co-Investigator on a 2024 Annual Pilot award with the Clinical and Translational ...
Session Type: E-Poster Poster No.: 145eTiP About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results